Literature DB >> 21475081

Ambulatory activity in individuals with multiple sclerosis.

James T Cavanaugh1, Victor O Gappmaier, Leland E Dibble, Eduard Gappmaier.   

Abstract

BACKGROUND AND
PURPOSE: Specific characteristics of physical activity limitations associated with multiple sclerosis (MS) remain unclear. Our purpose was to examine the impact of MS disability on physical activity behaviors involving ambulation. We also explored relationships among ambulatory activity parameters and clinical measures of gait, balance, and fatigue.
METHODS: Twenty-one adults with MS participated: 11 without ambulatory limitation (Expanded Disability Status Scale [EDSS] score ≤ 4.5) and 10 with ambulatory limitation (EDSS score > 4.5). Participants wore a step activity monitor for up to 7 days. Daily values were calculated for parameters indicative of (1) overall activity, (2) upper limits of activity output, and (3) activity work-rest cycles. Clinical measures included Multiple Sclerosis Walking Scale, Timed 25-Foot Walk, Timed Up and Go test, 6-Minute Walk, Dynamic Gait Index, Berg Balance Scale, Activities-specific Balance Confidence Scale, and Modified Fatigue Impact Scale. Statistical analyses were conducted using nonparametric tests.
RESULTS: Participants without limitation were more active, demonstrated higher upper limits of activity output, and had longer activity bouts than participants with limitation (P < 0.05). Only 1 participant averaged more than 100 steps per minute over a 30-minute period. Of the ambulatory activity parameters, daily step count was most strongly related to gait and balance measures. Of the clinical measures, EDSS and Multiple Sclerosis Walking Scale scores were most strongly related to daily step count.
CONCLUSION: Individuals with MS are not necessarily sedentary, but few may achieve recommended daily physical activity levels. Ambulatory activity characteristics revealed new insights into physical activity limitations in MS. The study findings suggest that disability status should direct physical activity interventions.

Entities:  

Mesh:

Year:  2011        PMID: 21475081     DOI: 10.1097/NPT.0b013e3182097190

Source DB:  PubMed          Journal:  J Neurol Phys Ther        ISSN: 1557-0576            Impact factor:   3.649


  34 in total

1.  Capturing ambulatory activity decline in Parkinson's disease.

Authors:  James T Cavanaugh; Terry D Ellis; Gammon M Earhart; Matthew P Ford; K Bo Foreman; Leland E Dibble
Journal:  J Neurol Phys Ther       Date:  2012-06       Impact factor: 3.649

2.  Use of Accelerometers to Measure Real-Life Physical Activity in Ambulatory Individuals with Multiple Sclerosis: A Pilot Study.

Authors:  Cecilie Fjeldstad; Anette S Fjeldstad; Gabriel Pardo
Journal:  Int J MS Care       Date:  2015 Sep-Oct

3.  Understanding walking activity in multiple sclerosis: step count, walking intensity and uninterrupted walking activity duration related to degree of disability.

Authors:  An Neven; Annelien Vanderstraeten; Davy Janssens; Geert Wets; Peter Feys
Journal:  Neurol Sci       Date:  2016-05-20       Impact factor: 3.307

4.  Continuous daily assessment of multiple sclerosis disability using remote step count monitoring.

Authors:  V J Block; A Lizée; E Crabtree-Hartman; C J Bevan; J S Graves; R Bove; A J Green; B Nourbakhsh; M Tremblay; P-A Gourraud; M Y Ng; M J Pletcher; J E Olgin; G M Marcus; D D Allen; B A C Cree; J M Gelfand
Journal:  J Neurol       Date:  2016-11-28       Impact factor: 4.849

5.  Toward Understanding Ambulatory Activity Decline in Parkinson Disease.

Authors:  James T Cavanaugh; Terry D Ellis; Gammon M Earhart; Matthew P Ford; K Bo Foreman; Leland E Dibble
Journal:  Phys Ther       Date:  2015-04-09

6.  Quantity and quality of gait and turning in people with multiple sclerosis, Parkinson's disease and matched controls during daily living.

Authors:  Vrutangkumar V Shah; James McNames; Martina Mancini; Patricia Carlson-Kuhta; Rebecca I Spain; John G Nutt; Mahmoud El-Gohary; Carolin Curtze; Fay B Horak
Journal:  J Neurol       Date:  2020-01-11       Impact factor: 4.849

7.  Self-efficacy as a predictor of self-reported physical, cognitive, and social functioning in multiple sclerosis.

Authors:  Margaret M Schmitt; Yael Goverover; John Deluca; Nancy Chiaravalloti
Journal:  Rehabil Psychol       Date:  2013-12-09

8.  The descriptive epidemiology of daily sitting time as a sedentary behavior in multiple sclerosis.

Authors:  Elizabeth A Hubbard; Robert W Motl; Patricia J Manns
Journal:  Disabil Health J       Date:  2015-06-26       Impact factor: 2.554

9.  Validity and Reliability of Four Clinical Gait Measures in Patients with Multiple Sclerosis.

Authors:  Susan E Bennett; Lacey E Bromley; Nadine M Fisher; Machiko R Tomita; Paulette Niewczyk
Journal:  Int J MS Care       Date:  2017 Sep-Oct

10.  Critical Appraisal of Evidence for Improving Gait Speed in People with Multiple Sclerosis: Dalfampridine Versus Gait Training.

Authors:  Prudence Plummer
Journal:  Int J MS Care       Date:  2016 May-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.